Wednesday, November 25, 2009, 1:54am EST - Canadian Markets open in 7 hours and 36 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Chembio Diagnostics, Inc. (CEMI.OB)

On Nov 24: 0.31 USD  Down 0.01 (3.13%)  
MORE ON CEMI.OB
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
CHEMBIO DIAGNOSTICS (OTC BB:CEMI.OB) Delayed quote dataEdit
Last Trade: 0.31 USD
Trade Time: Nov 24
Change: Down 0.01 (3.13%)
Prev Close: 0.32
Open: 0.32
Bid: 0.31 x 5000
Ask: 0.32 x 5000
1y Target Est: 0.50
Day's Range: 0.30 - 0.32
52wk Range: 0.08 - 0.57
Volume: 140,988
Avg Vol (3m): 41,450
Market Cap: 19.20M
P/E (ttm): N/A
EPS (ttm): -0.01
Div & Yield: N/A (N/A%)
Chembio Diagnostics, Inc. (CEMI.OB)
1d  5d  3m  6m  1y  2y  5y 
 Add CEMI.OB to Portfolio   Download Data

HEADLINES
CHEMBIO DIAGNOSTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
EDGAR Online (Tue, Nov 17)
Chembio Diagnostics to Present at the FDA Blood Products Advisory Committee on November 17, 2009
Marketwire (Tue, Nov 17)
CHEMBIO DIAGNOSTICS, INC. Financials
EDGAR Online Financials (Tue, Nov 10)
CHEMBIO DIAGNOSTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
EDGAR Online (Wed, Nov 4)
Chembio Reports Third Quarter 2009 Results
Marketwire (Wed, Nov 4)
CHEMBIO DIAGNOSTICS, INC. Files SEC form 10-Q, Quarterly Report
EDGAR Online (Wed, Nov 4)
Q3 2009 CHEMBIO DIAGNOSTICS INC Earnings Release - After Market Close
CCBN (Wed, Nov 4)
CHEMBIO DIAGNOSTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
EDGAR Online (Wed, Oct 28)
Chembio to Host Conference Call to Discuss Third Quarter 2009 Financial Results
Marketwire (Tue, Oct 27)
CHEMBIO DIAGNOSTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
EDGAR Online (Tue, Oct 20)
More Headlines for CEMI.OB...

ANALYST
EPS Est (next year) (Dec-08) : N/A
EPS Est (in 2 years) (Dec-09) : N/A
Avg Rec (current)*: 3.0
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and markets rapid diagnostic tests for the detection of HIV antibodies in whole blood, serum, and plasma samples.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News Canadian Indices